SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001628280-21-012358
Filing Date
2021-06-16
Accepted
2021-06-16 17:10:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D schedule13d-paragmallick.htm SC 13D 50824
  Complete submission text file 0001628280-21-012358.txt   52182
Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Subject) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91615 | Film No.: 211022278
SIC: 6770 Blank Checks

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 201 INDUSTRIAL RD. #310 SAN CARLOS CA 94070
Business Address
Mallick Parag (Filed by) CIK: 0001857948 (see all company filings)

Type: SC 13D